The role of routing in the diagnosis of acute leukemia in children: an observational retrospective non-randomized study

Abstract

BACKGROUND: Acute leukemia is the commonest malignancy of childhood with an incidence rate of about 55–62 per 1 million under 18 years of age. Early diagnosis of acute leukemia is difficult due to the non-specificity of primary symptoms, which are often hidden under the “masks” of other diseases. This problem is especially relevant for regions with a population of up to 100 thousand people, where a case of acute leukemia in children occurs every 2–5 years causing too low oncological alertness among pediatricians.

AIM: Assess the delay in diagnosis depending on the areas of residence in the Tver region and area remoteness from the Tver Regional Clinical Children’s Hospital (Tver, Russia).

MATERIALS AND METHODS: The analysis included 35 patients hospitalized in the Department of Oncology and hematology of the Tver Regional Clinical Children’s Hospital for the period from 2018 to 2023. The diagnoses were: acute lymphocytic leukemia (C91.0) — 30 (86%) patients, acute myeloid leukemia (C92) — 3 (9%) patients, and acute leukemia of unspecified cell type (C95.0) — 2 (5%) patients. The mean age was 61 months (5.1 years). Thrombocytopenia and anemia at the time of diagnosis were found in 76% and 78%, respectively. Leukocytosis (> 20×10⁹/L) was observed in 58%, leukopenia (<3.5×10⁹/L) in 15% of patients. In 97% of cases blasts (2% to 95%) were detected in peripheral blood. In the city of Tver (Group 1) and the Tver region (Group 2), 16 (46%) and 19 (54%) patients were identified, respectively. The mean age of patients in Group 1 is 28.6 months, and in Group 2 — 72.3 months (p=0.1).

RESULTS: In Groups 1 and 2, acute lymphocytic leukemia was diagnosed in 14 (88%) and 16 (84%), respectively (p=0.6); acute myeloid leukemia — in 1 (6%) and 2 (11%), respectively (p=0.7); acute leukemia of unspecified cell type — in 1 (6%) and 1 (5%) cases, respectively (p=0.95). Delay of diagnosis in the general group (n=35) was observed as follows: <2 weeks — in 21 (60%) cases; 2–4 weeks — in 7 (20%) cases; 4–8 weeks — in 4 (11%) cases: >8 weeks — in 3 (9%) cases. Comparison of the time of delayed diagnosis among patients living in the city of Tver versus the Tver region yielded following results: <2 weeks in 7 (44%) vs 13 (68%) cases; 2–4 weeks — in 6 (38%) vs 3 (17%), 4–8 weeks — in 1 (6%) vs 1 (5%); >8 weeks — in 2 (12%) vs 2 (10%) cases, respectively (p=0.37). There was no significant impact of the distance of the residence place from the level 3 children’s hospital providing specialized care on the time of diagnosis. With the patients’ distance of <50 km from the clinic, the diagnosis delay of <2 weeks, 2–4 weeks, 4–8 weeks and >8 weeks was observed in 36%, 36%, 21% and 7% of cases, respectively. With the distance of 50–100 km, the diagnosis was made in the period of 2–4 weeks in 100% of cases. With the removal of >100 km the diagnosis delay of <2 weeks, 2–4 weeks, 4–8 weeks, >8 weeks was observed in 30%, 30%, 20% and 20%, respectively (p=0.78).

CONCLUSION: The distance from the third-level hospital did not affect the period of diagnosis of acute leukemia in children. We believe this is achieved by holding daily on-line conferences with country hospitals and out-patient departments followed by the rapid hospitalization of children with suspected oncohematological disorders in the specialized department.

Keywords

acute leukemia / children / delay in diagnosis / distance / third-level hospital

References

[1] Zwaan CM, Kolb EA, Reinhardt D, et al. Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. J Clin Oncol. 2015;33(27):2949–2962. doi: 10.1200/JCO.2015.62.8289

[2] Zwaan C.M., Kolb E.A., Reinhardt D., et al. Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia // J Clin Oncol. 2015. Vol. 33, N 27. P. 2949–2962. doi: 10.1200/JCO.2015.62.8289

[3] Pui CH, Yang JJ, Hunger SP, et al. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. J Clin Oncol. 2015;33(27):2938–2948. doi: 10.1200/JCO.2014.59.1636

[4] Pui C.H., Yang J.J., Hunger S.P., et al. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration // J Clin Oncol. 2015. Vol. 33, N 27. P. 2938–2948. doi: 10.1200/JCO.2014.59.1636

[5] Alexander TB, Wang L, Inaba H, et al. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials. Cancer. 2017;123(19):3791–3798. doi: 10.1002/cncr.30791

[6] Alexander T.B., Wang L., Inaba H., et al. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials // Cancer. 2017. Vol. 123, N 19. P. 3791–3798. doi: 10.1002/cncr.30791

[7] Rotz SJ, Wei W, Thomas SM, Hanna R. Distance to treatment center is associated with survival in children and young adults with acute lymphoblastic leukemia. Cancer. 2020;126(24):5319–5327. doi: 10.1002/cncr.33175

[8] Rotz S.J., Wei W., Thomas S.M., Hanna R. Distance to treatment center is associated with survival in children and young adults with acute lymphoblastic leukemia // Cancer. 2020. Vol. 126, N 24. P. 5319–5327. doi: 10.1002/cncr.33175

[9] Brand NR, Qu LG, Chao A, Ilbawi AM. Delays and Barriers to Cancer Care in Low- and Middle-Income Countries: A Systematic Review. Oncologist. 2019;24(12):e1371–e1380. doi: 10.1634/theoncologist.2019-0057

[10] Brand N.R., Qu L.G., Chao A., Ilbawi A.M. Delays and Barriers to Cancer Care in Low- and Middle-Income Countries: A Systematic Review // Oncologist. 2019. Vol. 24, N 12. P. e1371–e1380. doi: 10.1634/theoncologist.2019-0057

[11] Dai Q, Liu R, Wang Y, et al. Longer Time Intervals From Symptom Onset to Diagnosis Affect the Overall Survival in Children With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 2021;44:285–292. doi: 10.1097/MPH.0000000000002344

[12] Dai Q., Liu R., Wang Y., et al. Longer Time Intervals From Symptom Onset to Diagnosis Affect the Overall Survival in Children With Acute Lymphoblastic Leukemia // Journal of Pediatric Hematology/Oncology. 2021. Vol. 44. P. 285–292. doi: 10.1097/MPH.0000000000002344

[13] Guide to cancer early diagnosis. Geneva: World Health Organization; 2017.

[14] Guide to cancer early diagnosis. Geneva : World Health Organization, 2017.

[15] Flytkjær Virgilsen L, Møller H, Vedsted P. Cancer diagnostic delays and travel distance to health services: A nationwide cohort study in Denmark. Cancer Epidemiol. 2019;59:115–122. doi: 10.1016/j.canep.2019.01.018

[16] Flytkjær Virgilsen L., Møller H., Vedsted P. Cancer diagnostic delays and travel distance to health services: A nationwide cohort study in Denmark // Cancer Epidemiol. 2019. Vol. 59. P. 115–122. doi: 10.1016/j.canep.2019.01.018

[17] Lins MM, Amorim M, Vilela P, et al. Delayed diagnosis of leukemia and association with morbid-mortality in children in Pernambuco, Brazil. J Pediatr Hematol Oncol. 2012;34(7):271–276. doi: 10.1097/MPH.0b013e3182580bea

[18] Lins M.M., Amorim M., Vilela P., et al. Delayed diagnosis of leukemia and association with morbid-mortality in children in Pernambuco, Brazil // J Pediatr Hematol Oncol. 2012. Vol. 34, N 7. P. 271–276. doi: 10.1097/MPH.0b013e3182580bea

[19] Begum M, Islam MJ, Akhtar MW, Karim S. Evaluation of delays in diagnosis and treatment of childhood malignancies in Bangladesh. South Asian J Cancer. 2016;5(4):192–193. doi: 10.4103/2278-330X.195343

[20] Begum M., Islam M.J., Akhtar M.W., Karim S. Evaluation of delays in diagnosis and treatment of childhood malignancies in Bangladesh // South Asian J Cancer. 2016. Vol. 5, N 4. P. 192–193. doi: 10.4103/2278-330X.195343

[21] Fajardo-Gutiérrez A, Sandoval-Mex AM, Mejía-Aranguré JM, et al. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Med Pediatr Oncol. 2002;39(1):25–31. doi: 10.1002/mpo.10100

[22] Fajardo-Gutiérrez A., Sandoval-Mex A.M., Mejía-Aranguré J.M., et al. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer // Med Pediatr Oncol. 2002. Vol. 39, N 1. P. 25–31. doi: 10.1002/mpo.10100

[23] Baker JM, To T, Beyene J, et al. Influence of length of time to diagnosis and treatment on the survival of children with acute lymphoblastic leukemia: a population-based study. Leuk Res. 2014;38(2):204–209. doi: 10.1016/j.leukres.2013.11.014

[24] Baker J.M., To T., Beyene J., et al. Influence of length of time to diagnosis and treatment on the survival of children with acute lymphoblastic leukemia: a population-based study // Leuk Res. 2014. Vol. 38, N 2. P. 204–209. doi: 10.1016/j.leukres.2013.11.014

[25] Hailu A, Mekasha A, Hailu D, et al. Impact of delay prior to treatment in Ethiopian children with acute lymphoblastic leukemia. Pediatric Health Med Ther. 2023;14:147–157. doi: 10.2147/PHMT.S406181

[26] Hailu A., Mekasha A., Hailu D., et al. Impact of delay prior to treatment in Ethiopian children with acute lymphoblastic leukemia // Pediatric Health Med Ther. 2023. Vol. 14. P. 147–157. doi: 10.2147/PHMT.S406181

[27] Sergentanis T, Dessypris N, Kanavidis P, et al. Socioeconomic status, area remoteness, and survival from childhood leukemia: results from the Nationwide Registry for Childhood Hematological Malignancies in Greece. Eur J Cancer Prev. 2013;22(5):473–479. doi: 10.1097/CEJ.0b013e32835c7f69

[28] Sergentanis T., Dessypris N., Kanavidis P., et al. Socioeconomic status, area remoteness, and survival from childhood leukemia: results from the Nationwide Registry for Childhood Hematological Malignancies in Greece // Eur J Cancer Prev. 2013. Vol. 22, N 5. P. 473–479. doi: 10.1097/CEJ.0b013e32835c7f69

[29] Gardie Y, Wassie M, Wodajo S, et al. Delay in diagnosis and associated factors among children with cancer admitted at pediatric oncology ward, University of Gondar comprehensive specialized hospital, Ethiopia: a retrospective cross-sectional study. BMC Cancer. 2023;23(1):469. doi: 10.1186/s12885-023-10873-8

[30] Gardie Y., Wassie M., Wodajo S., et al. Delay in diagnosis and associated factors among children with cancer admitted at pediatric oncology ward, University of Gondar comprehensive specialized hospital, Ethiopia: a retrospective cross-sectional study // BMC Cancer. 2023. Vol. 23, N 1. P. 469. doi: 10.1186/s12885-023-10873-8

[31] De Angelis C, Pacheco C, Lucchini G, et al. The experience in Nicaragua: childhood leukemia in low income countries—the main cause of late diagnosis may be “medical delay”. Int J Pediatr. 2012;2012. doi: 10.1155/2012/129707

[32] De Angelis C., Pacheco C., Lucchini G., et al. The experience in Nicaragua: childhood leukemia in low income countries—the main cause of late diagnosis may be “medical delay” // Int J Pediatr. 2012. Vol. 2012. doi: 10.1155/2012/129707

[33] Tamefusa K, Ochi M, Ishida H, et al. Delayed diagnostic interval and survival outcomes in pediatric leukemia: A single-center, retrospective study. Eur J Haematol. 2023. doi: 10.1111/ejh.14162

[34] Tamefusa K., Ochi M., Ishida H., et al. Delayed diagnostic interval and survival outcomes in pediatric leukemia: A single-center, retrospective study // Eur J Haematol. 2023. doi: 10.1111/ejh.14162

[35] Charalampopoulou A, Petridou E, Spyridopoulos T, et al. An integrated evaluation of socioeconomic and clinical factors in the survival from childhood acute lymphoblastic leukaemia: a study in Greece. Eur J Cancer Prev. 2004;13(5):397–401. doi: 10.1097/00008469-200410000-00007

[36] Charalampopoulou A., Petridou E., Spyridopoulos T., et al. An integrated evaluation of socioeconomic and clinical factors in the survival from childhood acute lymphoblastic leukaemia: a study in Greece // Eur J Cancer Prev. 2004. Vol. 13, N 5. P. 397–401. doi: 10.1097/00008469-200410000-00007

[37] Youlden DR, Baade PD, Valery PC, et al. Differentials in survival for childhood cancer in Australia by remoteness of residence and area disadvantage. Cancer epidemiology, biomarkers & prevention. 2011;20(8):1649–1656. doi: 10.1158/1055-9965.Epi-11-0432

[38] Youlden D.R., Baade P.D., Valery P.C., et al. Differentials in survival for childhood cancer in Australia by remoteness of residence and area disadvantage // Cancer epidemiology, biomarkers & prevention. 2011. Vol. 20, N 8. P. 1649–1656. doi: 10.1158/1055-9965.Epi-11-0432

[39] Janitz AE, Barber R, Campbell JE, et al. Measuring disparities in event-free survival among children with acute lymphoblastic leukemia in an academic institute in Oklahoma, 2005-2019. Cancer Epidemiol. 2022;81:102275. doi: 10.1016/j.canep.2022.102275

[40] Janitz A.E., Barber R., Campbell J.E., et al. Measuring disparities in event-free survival among children with acute lymphoblastic leukemia in an academic institute in Oklahoma, 2005-2019 // Cancer Epidemiol. 2022. Vol. 81. P. 102275. doi: 10.1016/j.canep.2022.102275

[41] Cancer Stat Facts: Childhood Leukemia [Internet]. National Cancer Institute. [cited 2024 Mar 10]. Available from: https://seer.cancer.gov/statfacts/html/childleuk.html

[42] Cancer Stat Facts: Childhood Leukemia [Internet]. National Cancer Institute. [дата обращения: 10.03.2024]. Доступ по ссылке: https://seer.cancer.gov/statfacts/html/childleuk.html

RIGHTS & PERMISSIONS

Eco-Vector